Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-dose, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dysport for the Treatment of Pain Associated With Hallux Abducto Valgus

NCT03569098 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03569098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-dose, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dysport for the Treatment of Pain Associated With Hallux Abducto Valgus
Lead sponsor
Ipsen
Phase
Phase 2
Overall status
Completed
Start date
June 19, 2018
Completion date
May 22, 2020
Enrollment
186 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

hallux abducto valgus